Yang W, Benjamin I S, Alexander B
Academic Department of Surgery, Liver Sciences Unit, Guy's, King's and St Thomas' School of Medicine, St Thomas' Hospital, London, UK.
Acta Physiol Scand. 2001 Apr;171(4):413-8. doi: 10.1046/j.1365-201X.2001.00809.x.
The role of nitric oxide in the modulation of hepatic arterial vascular reactivity was investigated in an isolated dual-perfused rat liver preparation. Twelve male Wistar rats (200-250 g) were anaesthetized with sodium pentobarbitone (60 mg kg-1 i.p.). The livers were then excised and perfused in vitro through hepatic arterial and portal venous cannulae at constant flow rates. Concentration-dependent dose-response curves to acetylcholine (10(-8)-10(-5) M), sodium nitroprusside (10-6(-5) x 10(-4) M), and adenosine triphosphate (ATP) (10(-8)-10(-5) M) in the hepatic artery were constructed after the tone was raised by addition of methoxamine (3 micorM L(-1)). Acetylcholine-induced vasodilatation in the hepatic artery was significantly attenuated with inhibition of nitric oxide synthase by using NG-nitro-L-arginine methyl ester (30 microM), Emax = 51.7 +/- 2.8 vs. 32.5 +/- 3.1 mmHg, before vs. after NG-nitro-L-arginine methyl ester, respectively. ATP-induced hepatic arterial vasoconstriction which was significantly enhanced with L-NAME, Emax = 94.0 +/- 9.3 vs. 127.0 +/- 8.0 mmHg, before vs. after NG-nitro-L-arginine methyl ester, respectively. Sodium nitroprusside-induced hepatic arterial vasodilatation remained unchanged with NG-nitro-L-arginine methyl ester, Emax = 57.0 +/- 3.4 vs. 57.0 +/- 4.1, before vs. after NG-nitro-L-arginine methyl ester, respectively. The data from the present study suggest that acetylcholine-induced vasodilatation in the intrahepatic arterial vasculature of the rat liver is at least, in part, mediated by the release of nitric oxide. In addition, ATP-induced hepatic arterial vasoconstriction is also modulated by the release of nitric oxide (*P < 0.05, Student's paired t-test).
在一个分离的双灌注大鼠肝脏制备模型中,研究了一氧化氮在调节肝动脉血管反应性中的作用。12只雄性Wistar大鼠(200 - 250克)用戊巴比妥钠(60毫克/千克腹腔注射)麻醉。然后切除肝脏,并通过肝动脉和门静脉插管在体外以恒定流速进行灌注。在加入甲氧明(3微摩尔/升)使张力升高后,构建肝动脉对乙酰胆碱(10^(-8) - 10^(-5) 摩尔/升)、硝普钠(10^(-6) - 5×10^(-4) 摩尔/升)和三磷酸腺苷(ATP)(10^(-8) - 10^(-5) 摩尔/升)的浓度依赖性剂量反应曲线。使用NG - 硝基 - L - 精氨酸甲酯(30微摩尔)抑制一氧化氮合酶后,乙酰胆碱诱导的肝动脉血管舒张明显减弱,分别为最大效应(Emax)= 51.7±2.8毫米汞柱(NG - 硝基 - L - 精氨酸甲酯前)和32.5±3.1毫米汞柱(NG - 硝基 - L - 精氨酸甲酯后)。L - 硝基精氨酸甲酯使ATP诱导的肝动脉血管收缩显著增强,分别为最大效应(Emax)= 94.0±9.3毫米汞柱(NG - 硝基 - L - 精氨酸甲酯前)和127.0±8.0毫米汞柱(NG - 硝基 - L - 精氨酸甲酯后)。硝普钠诱导的肝动脉血管舒张在使用NG - 硝基 - L - 精氨酸甲酯后保持不变,分别为最大效应(Emax)= 57.0±3.4(NG - 硝基 - L - 精氨酸甲酯前)和57.0±4.1(NG - 硝基 - L - 精氨酸甲酯后)。本研究数据表明,大鼠肝脏肝内动脉血管系统中乙酰胆碱诱导的血管舒张至少部分是由一氧化氮的释放介导的。此外,ATP诱导的肝动脉血管收缩也受到一氧化氮释放的调节(*P < 0.05,学生配对t检验)。